The mission of our clinical research is to foster discoveries in the novel therapies of inflammatory bowel diseases, gastrointestinal and pancreatic cancer, hepatitis, and other gastrointestinal disorders. Our doctors are committed to providing the best care and management of diseases while testing cutting-edge therapies.

Back to full list of clinical trials

Ongoing clinical trials for cholangiocarcinoma and pancreatic cancer: Actively recruiting


Condition:

Cholangiocarcinoma, pancreatic cancer

Study title:

Endoscopic Radiofrequency Ablation of Malignant Bile Duct Strictures: A pilot study

Description of study:

This is a prospective pilot study of endoscopic ablation of a malignant bile duct stricture with ERCP guided radiofrequency ablation. Patients undergo one treatment during ERCP and resume their standard medical or surgical care after the procedure.

Basic eligibility criteria:

Patients must have evidence of biliary obstruction by imaging and laboratory testing, as well as evidence of malignancy.

Principal Investigator:

William Brugge, MD

Contact:

Ebubekir Daglilar, MD, CRC; 617-724-0462

For more information: Visit the Clinical Trials website at the National Institutes of Health